Curis currently offers the following benefits. There is no waiting period for coverage, unless otherwise stated. Benefits are subject to change from time to time.
The company says its mission is to develop therapeutics that improve the lives of cancer patients and lists respect, compassion, empowerment, and commitment among its core values.
The page explains that the fermata above the “i” in Curis denotes a prolonged note, an indefinite rest, or the closing of a piece; Curis applies the symbol to its development of cancer therapies.
The page lists Curis Inc at 128 Spring Street, Building C- Suite 500, Lexington, MA 02421, phone (617) 503-6500, and info@curis.com. Fields marked * are required; submitted information is subject to the Privacy Policy.
Curis is a biotechnology company developing and commercializing cancer therapeutics. It has three drug candidates in development, including Fimepinostat, an orally available small-molecule inhibitor of HDAC and PI3K enzymes in a Phase 2 trial.
Curis, Inc. owns and operates the website and provides its materials for informational purposes to customers, potential customers, and the general public.
